{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T19:48:56Z","timestamp":1790884136222,"version":"4.1.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2021,8,7]],"date-time":"2021-08-07T00:00:00Z","timestamp":1628294400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,8,7]],"date-time":"2021-08-07T00:00:00Z","timestamp":1628294400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Partnership UMCG Siemens for building the future of Health","award":["O682734"],"award-info":[{"award-number":["O682734"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Cardiol Rep"],"published-print":{"date-parts":[[2021,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Purpose of Review<\/jats:title>\n                <jats:p>Additional imaging modalities, such as FDG-PET\/CT, have been included into the workup for patients with suspected infective endocarditis, according to major international guidelines published in 2015. The purpose of this review is to give an overview of FDG-PET\/CT indications and standardized approaches in the setting of suspected infective endocarditis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Recent Findings<\/jats:title>\n                <jats:p>There are two main indications for performing FDG-PET\/CT in patients with suspected infective endocarditis: (i) detecting intracardiac infections and (ii) detection of (clinically silent) disseminated infectious disease. The diagnostic performance of FDG-PET\/CT for intracardiac lesions depends on the presence of native valves, prosthetic valves, or implanted cardiac devices, with a sensitivity that is poor for native valve endocarditis and cardiac device-related lead infections, but much better for prosthetic valve endocarditis and cardiac device-related pocket infections. Specificity is high for all these indications. The detection of disseminated disease may also help establish the diagnosis and\/or impact patient management.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Summary<\/jats:title>\n                <jats:p>Based on current evidence, FDG-PET\/CT should be considered for detection of disseminated disease in suspected endocarditis. Absence of intracardiac lesions on FDG-PET\/CT cannot rule out native valve endocarditis, but positive findings strongly support the diagnosis. For prosthetic valve endocarditis, standard use of FDG-PET\/CT is recommended because of its high sensitivity and specificity. For implanted cardiac devices, FDG-PET\/CT is also recommended, but should be evaluated with careful attention to clinical context, because its sensitivity is high for pocket infections, but low for lead infections. In patients with prosthetic valves with or without additional aortic prosthesis, combination with CTA should be considered. Optimal timing of FDG-PET\/CT is important, both during clinical workup and technically (i.e., post tracer injection). In addition, procedural standardization is key and encompasses patient preparation, scan acquisition, reconstruction, subsequent analysis, and clinical interpretation. The recommendations discussed here will hopefully contribute to improved standardization and enhanced performance of FDG-PET\/CT in the clinical management of patients with suspected infective endocarditis.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s11886-021-01542-y","type":"journal-article","created":{"date-parts":[[2021,8,6]],"date-time":"2021-08-06T23:20:07Z","timestamp":1628292007000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":81,"title":["18F-FDG PET\/CT in Infective Endocarditis: Indications and Approaches for Standardization"],"prefix":"10.1007","volume":"23","author":[{"given":"D.","family":"ten Hove","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.H.J.A.","family":"Slart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Sinha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.W.J.M.","family":"Glaudemans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.P.J.","family":"Budde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,8,7]]},"reference":[{"issue":"10021","key":"1542_CR1","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1016\/S0140-6736(15)00067-7","volume":"387","author":"TJ Cahill","year":"2016","unstructured":"Cahill TJ, Prendergast BD. Infective endocarditis. Lancet. 2016;387(10021):882\u201393.","journal-title":"Lancet."},{"key":"1542_CR2","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.ijcard.2020.10.029","volume":"326","author":"AD Jensen","year":"2021","unstructured":"Jensen AD, Bundgaard H, Butt JH, Bruun NE, Voldstedlund M, Torp-Pedersen C, et al. Temporal changes in the incidence of infective endocarditis in Denmark 1997-2017: a nationwide study. Int J Cardiol. 2021;326:145\u201352.","journal-title":"Int J Cardiol"},{"issue":"10","key":"1542_CR3","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1007\/s11606-018-4514-7","volume":"33","author":"M Heredia-Rodr\u00edguez","year":"2018","unstructured":"Heredia-Rodr\u00edguez M, Hern\u00e1ndez A, Bustamante-Munguira J, \u00c1lvarez FJ, Eiros JM, Castrodeza J, et al. Evolution of the incidence, mortality, and cost of infective endocarditis in Spain between 1997 and 2014. J Gen Intern Med. 2018;33(10):1610\u20133.","journal-title":"J Gen Intern Med"},{"issue":"2","key":"1542_CR4","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1093\/ehjqcco\/qcw039","volume":"3","author":"FS van den Brink","year":"2017","unstructured":"van den Brink FS, Swaans MJ, Hoogendijk MG, Alipour A, Kelder JC, Jaarsma W, et al. Increased incidence of infective endocarditis after the 2009 European Society of Cardiology guideline update: a nationwide study in the Netherlands. Eur Heart J Qual Care Clin Outcomes. 2017;3(2):141\u20137.","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"issue":"10","key":"1542_CR5","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0223857","volume":"14","author":"S Sunder","year":"2019","unstructured":"Sunder S, Grammatico-Guillon L, Lemaignen A, Lacasse M, Gaborit C, Boutoille D, et al. Incidence, characteristics, and mortality of infective endocarditis in France in 2011. PLoS One. 2019;14(10):e0223857.","journal-title":"PLoS One"},{"key":"1542_CR6","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1086\/313753","volume":"30","author":"JS Li","year":"2000","unstructured":"Li JS, Sexton DJ, Mick N, Nettles R, Fowler VG, Ryan T, et al. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis. 2000;30:633\u20138.","journal-title":"Clin Infect Dis"},{"issue":"6","key":"1542_CR7","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1136\/hrt.2003.029850","volume":"90","author":"BD Prendergast","year":"2004","unstructured":"Prendergast BD. Diagnostic criteria and problems in infective endocarditis. Heart. 2004 Jun;90(6):611\u20133.","journal-title":"Heart."},{"issue":"44","key":"1542_CR8","doi-asserted-by":"publisher","first-page":"3075","DOI":"10.1093\/eurheartj\/ehv319","volume":"36","author":"G Habib","year":"2015","unstructured":"Habib G, Lancellotti P, Antunes MJ, Bongiorni MG, Casalta JP, Del Zotti F, et al. Zamorano JL; ESC Scientific Document Group. 2015 ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Eur Heart J. 2015;36(44):3075\u2013128.","journal-title":"Eur Heart J"},{"issue":"15","key":"1542_CR9","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1161\/CIR.0000000000000296","volume":"132","author":"LM Baddour","year":"2015","unstructured":"Baddour LM, Wilson WR, Bayer AS, Fowler VG Jr, Tleyjeh IM, Rybak MJ, et al. American Heart Association Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease of the Council on Cardiovascular Disease in the Young, Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and Stroke Council. Infective endocarditis in adults: diagnosis, antimicrobial therapy, and management of complications: a scientific statement for healthcare professionals from the American Heart Association. Circulation. 2015;132(15):1435\u201386.","journal-title":"Circulation"},{"issue":"1","key":"1542_CR10","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.cmi.2014.08.012","volume":"21","author":"K Orvin","year":"2015","unstructured":"Orvin K, Goldberg E, Bernstine H, Groshar D, Sagie A, Kornowski R, et al. The role of FDG-PET\/CT imaging in early detection of extra-cardiac complications of infective endocarditis. Clin Microbiol Infect. 2015;21(1):69\u201376.","journal-title":"Clin Microbiol Infect"},{"issue":"10","key":"1542_CR11","doi-asserted-by":"publisher","first-page":"754","DOI":"10.3390\/diagnostics10100754","volume":"10","author":"CH Kamani","year":"2020","unstructured":"\u2022 Kamani CH, Allenbach G, Jreige M, Pavon AG, Meyer M, Testart N, et al. Diagnostic performance of 18F-FDG PET\/CT in native valve endocarditis: systematic review and bivariate meta-analysis. Diagnostics (Basel). 2020;10(10):754 This meta-analysis gives an overview of studies evaluating FDG-PET\/CT accuracy for suspected native valve endocarditis.","journal-title":"Diagnostics (Basel)"},{"issue":"1","key":"1542_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S1473-3099(16)30141-4","volume":"17","author":"A Gomes","year":"2017","unstructured":"Gomes A, Glaudemans AWJM, Touw DJ, van Melle JP, Willems TP, Maass AH, et al. Diagnostic value of imaging in infective endocarditis: a systematic review. Lancet Infect Dis. 2017;17(1):1\u201314.","journal-title":"Lancet Infect Dis"},{"issue":"6","key":"1542_CR13","doi-asserted-by":"publisher","first-page":"e010600","DOI":"10.1161\/CIRCIMAGING.120.010600","volume":"13","author":"W TKM","year":"2020","unstructured":"\u2022 TKM W, S\u00e1nchez-Nadales A, Igbinomwanhia E, Cremer P, Griffin B, Xu B. Diagnosis of infective endocarditis by subtype using 18F-fluorodeoxyglucose positron emission tomography\/computed tomography: a contemporary meta-analysis. Circ Cardiovasc Imaging. 2020;13(6):e010600 This meta-analysis gives an overview of studies evaluating FDG-PET\/CT accuracy for suspected infective endocarditis of native valves, prosthetic valves, and implanted cardiac devices.","journal-title":"Circ Cardiovasc Imaging"},{"issue":"9","key":"1542_CR14","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1016\/j.echo.2009.07.013","volume":"22","author":"WA Zoghbi","year":"2009","unstructured":"Zoghbi WA, Chambers JB, Dumesnil JG, Foster E, Gottdiener JS, Grayburn PA, et al. Zabalgoitia M; Recommendations for evaluation of prosthetic valves with echocardiography and Doppler ultrasound. J Am Soc Echocardiogr. 2009;22(9):975\u20131014.","journal-title":"J Am Soc Echocardiogr"},{"issue":"6","key":"1542_CR15","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1016\/j.jcmg.2020.01.020","volume":"13","author":"YA Lucinian","year":"2020","unstructured":"Lucinian YA, Lamarche Y, Demers P, Martineau P, Harel F, Pelletier-Galarneau M. FDG-PET\/CT for the detection of infection following aortic root replacement surgery. JACC Cardiovasc Imaging. 2020;13(6):1447\u20139.","journal-title":"JACC Cardiovasc Imaging"},{"issue":"3","key":"1542_CR16","doi-asserted-by":"publisher","first-page":"392","DOI":"10.2967\/jnumed.113.128173","volume":"55","author":"Z Keidar","year":"2014","unstructured":"Keidar Z, Pirmisashvili N, Leiderman M, Nitecki S, Israel O. 18F-FDG uptake in noninfected prosthetic vascular grafts: incidence, patterns, and changes over time. J Nucl Med. 2014;55(3):392\u20135.","journal-title":"J Nucl Med"},{"key":"1542_CR17","first-page":"202085","volume":"1","author":"A Gomes","year":"2018","unstructured":"Gomes A, van Geel PP, Santing M, Prakken NHJ, Ruis ML, van Assen S, et al. Imaging infective endocarditis: adherence to a diagnostic flowchart and direct comparison of imaging techniques. J Nucl Cardiol. 2018;1:202085.","journal-title":"J Nucl Cardiol"},{"issue":"5","key":"1542_CR18","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.2006.106716","volume":"94","author":"L Liao","year":"2008","unstructured":"Liao L, Kong DF, Samad Z, Pappas PA, Jollis JG, Lin SS, et al. Echocardiographic risk stratification for early surgery with endocarditis: a cost-effectiveness analysis. Heart. 2008;94(5):e18.","journal-title":"Heart."},{"key":"1542_CR19","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCIMAGING.116.005772","volume":"10","author":"D Juneau","year":"2017","unstructured":"Juneau D, Golfam M, Hazra S, Zuckier LS, Garas S, Redpath C, et al. Positron emission tomography and single-photon emission computed tomography imaging in the diagnosis of cardiac implantable electronic device infection: a systematic review and meta-analysis. Circ Cardiovasc Imaging. 2017;10:e005772.","journal-title":"Circ Cardiovasc Imaging"},{"key":"1542_CR20","doi-asserted-by":"crossref","unstructured":"Ten Hove D, Treglia G, Slart RHJA, Damman K, Wouthuyzen-Bakker M, Postma DF, et al. The value of 18F-FDG PET\/CT for the diagnosis of device-related infections in patients with a left ventricular assist device: a systematic review and meta-analysis. Eur J Nucl Med Mol Imaging. 2020.","DOI":"10.21203\/rs.3.rs-990449\/v1"},{"issue":"3","key":"1542_CR21","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1007\/s12350-014-9896-2","volume":"21","author":"L Leccisotti","year":"2014","unstructured":"Leccisotti L, Perna F, Lago M, Leo M, Stefanelli A, Calcagni ML, et al. Cardiovascular implantable electronic device infection: delayed vs standard FDG PET-CT imaging. J Nucl Cardiol. 2014;21(3):622\u201332.","journal-title":"J Nucl Cardiol"},{"issue":"14","key":"1542_CR22","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1161\/CIRCULATIONAHA.118.035032","volume":"138","author":"LE Swart","year":"2018","unstructured":"Swart LE, Gomes A, Scholtens AM, Sinha B, Tanis W, Lam MGEH, et al. Improving the diagnostic performance of 18F-fluorodeoxyglucose positron-emission tomography\/computed tomography in prosthetic heart valve endocarditis. Circulation. 2018;138(14):1412\u201327.","journal-title":"Circulation."},{"issue":"4","key":"1542_CR23","doi-asserted-by":"publisher","first-page":"647","DOI":"10.2967\/jnumed.112.112524","volume":"54","author":"F Jamar","year":"2013","unstructured":"Jamar F, Buscombe J, Chiti A, Christian PE, Delbeke D, Donohoe KJ, et al. EANM\/SNMMI guideline for 18F-FDG use in inflammation and infection. J Nucl Med. 2013;54(4):647\u201358.","journal-title":"J Nucl Med"},{"issue":"1","key":"1542_CR24","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1093\/ehjci\/jez222","volume":"21","author":"A Roque","year":"2020","unstructured":"Roque A, Pizzi MN, Fern\u00e1ndez-Hidalgo N, Permanyer E, Cuellar-Calabria H, Romero-Farina G, et al. Morpho-metabolic post-surgical patterns of non-infected prosthetic heart valves by [18F]FDG PET\/CTA: \u201cnormality\u201d is a possible diagnosis. Eur Heart J Cardiovasc Imaging. 2020;21(1):24\u201333.","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"1542_CR25","doi-asserted-by":"crossref","unstructured":"Wahadat AR, Tanis W, Scholtens AM, Bekker M, Graven LH, Swart LE, et al. Normal imaging findings after aortic valve implantation on 18F-Fluorodeoxyglucose positron emission tomography with computed tomography. J Nucl Cardiol. 2020.","DOI":"10.1093\/ehjci\/jez319.642"},{"issue":"2","key":"1542_CR26","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1007\/s00259-014-2961-x","volume":"42","author":"R Boellaard","year":"2015","unstructured":"Boellaard R, Delgado-Bolton R, Oyen WJ, Giammarile F, Tatsch K, Eschner W, et al. European Association of Nuclear Medicine (EANM). FDG PET\/CT: EANM procedure guidelines for tumour imaging: version 2.0. Eur J Nucl Med Mol Imaging. 2015;42(2):328\u201354.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"4","key":"1542_CR27","first-page":"1016","volume":"48","author":"S RHJA","year":"2020","unstructured":"\u2022\u2022 RHJA S, AWJM G, Gheysens O, Lubberink M, Kero T, Dweck MR, et al. 4Is cardiovascular imaging: a joint initiative of the European Association of Cardiovascular Imaging (EACVI); European Association of Nuclear Medicine (EANM). Procedural recommendations of cardiac PET\/CT imaging: standardization in inflammatory-, infective-, infiltrative-, and innervation (4Is)-related cardiovascular diseases: a joint collaboration of the EACVI and the EANM. Eur J Nucl Med Mol Imaging. 2020;48(4):1016\u201339 This publication provides an extensive overview of approaches for standardizing FDG-PET\/CT for evaluation of suspected cardiovascular disease.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1542_CR28","doi-asserted-by":"crossref","unstructured":"Williams G, Kolodny GM. Suppression of myocardial 18F-FDG uptake by preparing patients with a high-fat, low-carbohydrate diet. AJR Am J Roentgenol. 2008;190(2):W151\u20136.","DOI":"10.2214\/AJR.07.2409"},{"issue":"3","key":"1542_CR29","doi-asserted-by":"publisher","first-page":"185","DOI":"10.2967\/jnmt.110.076489","volume":"39","author":"H Balink","year":"2011","unstructured":"Balink H, Hut E, Pol T, Flokstra FJ, Roef M. Suppression of 18F-FDG myocardial uptake using a fat-allowed, carbohydrate-restricted diet. J Nucl Med Technol. 2011 Sep;39(3):185\u20139.","journal-title":"J Nucl Med Technol"},{"issue":"11","key":"1542_CR30","doi-asserted-by":"publisher","first-page":"2698","DOI":"10.1007\/s00259-020-04713-1","volume":"47","author":"AM Scholtens","year":"2020","unstructured":"Scholtens AM, van den Berk AM, van der Sluis NL, Esser JP, Lammers GK, de Klerk JMH, et al. Suppression of myocardial glucose metabolism in FDG PET\/CT: impact of dose variation in heparin bolus pre-administration. Eur J Nucl Med Mol Imaging. 2020;47(11):2698\u2013702.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"3","key":"1542_CR31","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1007\/s12350-019-01786-w","volume":"27","author":"SR Larson","year":"2020","unstructured":"Larson SR, Pieper JA, Hulten EA, Ficaro EP, Corbett JR, Murthy VL, et al. Characterization of a highly effective preparation for suppression of myocardial glucose utilization. J Nucl Cardiol. 2020;27(3):849\u201361.","journal-title":"J Nucl Cardiol"},{"issue":"2","key":"1542_CR32","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1007\/s12350-015-0226-0","volume":"23","author":"O Manabe","year":"2016","unstructured":"Manabe O, Yoshinaga K, Ohira H, Masuda A, Sato T, Tsujino I, et al. The effects of 18-h fasting with low-carbohydrate diet preparation on suppressed physiological myocardial (18)F-fluorodeoxyglucose (FDG) uptake and possible minimal effects of unfractionated heparin use in patients with suspected cardiac involvement sarcoidosis. J Nucl Cardiol. 2016;23(2):244\u201352.","journal-title":"J Nucl Cardiol"},{"issue":"1","key":"1542_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/2191-219X-4-1","volume":"4","author":"M Morooka","year":"2014","unstructured":"Morooka M, Moroi M, Uno K, Ito K, Wu J, Nakagawa T, et al. Long fasting is effective in inhibiting physiological myocardial 18F-FDG uptake and for evaluating active lesions of cardiac sarcoidosis. EJNMMI Res. 2014;4(1):1.","journal-title":"EJNMMI Res"},{"issue":"6","key":"1542_CR34","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.1007\/s12350-017-0902-3","volume":"25","author":"AM Scholtens","year":"2018","unstructured":"Scholtens AM, Swart LE, Verberne HJ, Budde RPJ, Lam MGEH. Dual-time-point FDG PET\/CT imaging in prosthetic heart valve endocarditis. J Nucl Cardiol. 2018 Dec;25(6):1960\u20137.","journal-title":"J Nucl Cardiol"},{"key":"1542_CR35","doi-asserted-by":"crossref","unstructured":"Wahadat AR, Tanis W, Swart LE, Scholtens A, Krestin GP, van Mieghem NMDA, et al. Added value of 18F-FDG-PET\/CT and cardiac CTA in suspected transcatheter aortic valve endocarditis. J Nucl Cardiol. 2019.","DOI":"10.1007\/s12350-019-01963-x"},{"issue":"12","key":"1542_CR36","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1016\/j.jcmg.2016.01.024","volume":"9","author":"AM Scholtens","year":"2016","unstructured":"Scholtens AM, Swart LE, Verberne HJ, Tanis W, Lam MG, Budde RP. Confounders in FDG-PET\/CT imaging of suspected prosthetic valve endocarditis. JACC Cardiovasc Imaging. 2016;9(12):1462\u20135. https:\/\/doi.org\/10.1016\/j.jcmg.2016.01.024.","journal-title":"JACC Cardiovasc Imaging"},{"issue":"5","key":"1542_CR37","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1007\/s00330-017-5163-7","volume":"28","author":"ME Faure","year":"2018","unstructured":"Faure ME, Swart LE, Dijkshoorn ML, Bekkers JA, van Straten M, Nieman K, et al. Advanced CT acquisition protocol with a third-generation dual-source CT scanner and iterative reconstruction technique for comprehensive prosthetic heart valve assessment. Eur Radiol. 2018;28(5):2159\u201368.","journal-title":"Eur Radiol"},{"issue":"2","key":"1542_CR38","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1007\/s11886-017-0825-2","volume":"19","author":"M Rubeaux","year":"2017","unstructured":"Rubeaux M, Doris MK, Alessio A, Slomka PJ. Enhancing cardiac PET by motion correction techniques. Curr Cardiol Rep. 2017;19(2):14.","journal-title":"Curr Cardiol Rep"},{"issue":"12","key":"1542_CR39","doi-asserted-by":"publisher","first-page":"1876","DOI":"10.2967\/jnumed.115.164285","volume":"56","author":"PJ Slomka","year":"2015","unstructured":"Slomka PJ, Rubeaux M, Le Meunier L, Dey D, Lazewatsky JL, Pan T, et al. Dual-gated motion-frozen cardiac PET with flurpiridaz F 18. J Nucl Med. 2015;56(12):1876\u201381.","journal-title":"J Nucl Med"},{"issue":"12","key":"1542_CR40","doi-asserted-by":"publisher","first-page":"2691","DOI":"10.1016\/j.jcmg.2020.06.036","volume":"13","author":"C Boursier","year":"2020","unstructured":"Boursier C, Duval X, Bourdon A, Imbert L, Mahida B, Chevalier E, et al. AEPEI-TEPvENDO study group. ECG-gated cardiac FDG PET acquisitions significantly improve detectability of infective endocarditis. JACC Cardiovasc Imaging. 2020;13(12):2691\u20133.","journal-title":"JACC Cardiovasc Imaging"},{"issue":"11","key":"1542_CR41","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1097\/MNM.0000000000001271","volume":"41","author":"M Yamanaka","year":"2020","unstructured":"Yamanaka M, Shinya T, Otomi Y, Kubo M, Arai Y, Toba H, et al. Semiquantitative assessment of fluorodeoxyglucose uptake in primary tumours on dynamic PET\/computed tomography for lymph node metastasis evaluation in patients with lung cancer: a prospective study. Nucl Med Commun. 2020;41(11):1189\u201398.","journal-title":"Nucl Med Commun"},{"key":"1542_CR42","doi-asserted-by":"publisher","first-page":"1678","DOI":"10.1007\/s00259-020-05121-1","volume":"48","author":"F Fu","year":"2021","unstructured":"Fu F, Li X, Wu Y, Xu J, Bai Y, Gao Y, et al. Total-body dynamic PET\/CT of micro-metastatic lymph node in a patient with lung cancer. Eur J Nucl Med Mol Imaging. 2021;48:1678\u20139.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"3","key":"1542_CR43","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1053\/j.semnuclmed.2018.02.003","volume":"48","author":"M Sollini","year":"2018","unstructured":"Sollini M, Berchiolli R, Kirienko M, Rossi A, Glaudemans AWJM, Slart R, et al. PET\/MRI in infection and inflammation. Semin Nucl Med. 2018;48(3):225\u201341.","journal-title":"Semin Nucl Med"},{"issue":"4","key":"1542_CR44","doi-asserted-by":"publisher","first-page":"e206","DOI":"10.1016\/S1470-2045(17)30189-4","volume":"18","author":"M Cavo","year":"2017","unstructured":"Cavo M, Terpos E, Nanni C, Moreau P, Lentzsch S, Zweegman S, et al. Role of 18F-FDG PET\/CT in the diagnosis and management of multiple myeloma and other plasma cell disorders: a consensus statement by the International Myeloma Working Group. Lancet Oncol. 2017;18(4):e206\u201317.","journal-title":"Lancet Oncol"},{"issue":"1","key":"1542_CR45","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1007\/s00259-018-4192-z","volume":"46","author":"AO Ankrah","year":"2019","unstructured":"Ankrah AO, Span LFR, Klein HC, de Jong PA, Dierckx RAJO, Kwee TC, et al. Role of FDG PET\/CT in monitoring treatment response in patients with invasive fungal infections. Eur J Nucl Med Mol Imaging. 2019;46(1):174\u201383.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1","key":"1542_CR46","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s13550-020-0591-9","volume":"10","author":"ST Malherbe","year":"2020","unstructured":"Malherbe ST, Chen RY, Dupont P, Kant I, Kriel M, Loxton AG, et al. Quantitative 18F-FDG PET-CT scan characteristics correlate with tuberculosis treatment response. EJNMMI Res. 2020;10(1):8.","journal-title":"EJNMMI Res"},{"issue":"6","key":"1542_CR47","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1007\/s00256-019-03328-4","volume":"49","author":"E Righi","year":"2020","unstructured":"Righi E, Carnelutti A, Muser D, Di Gregorio F, Cadeo B, Melchioretto G, et al. Incremental value of FDG-PET\/CT to monitor treatment response in infectious spondylodiscitis. Skelet Radiol. 2020;49(6):903\u201312.","journal-title":"Skelet Radiol"},{"issue":"11","key":"1542_CR48","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.1007\/s00259-018-4069-1","volume":"45","author":"L Husmann","year":"2018","unstructured":"Husmann L, Ledergerber B, Anagnostopoulos A, Stolzmann P, Sah BR, Burger IA, et al. Hasse B; VASGRA Cohort Study. The role of FDG PET\/CT in therapy control of aortic graft infection. Eur J Nucl Med Mol Imaging. 2018;45(11):1987\u201397.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"13","key":"1542_CR49","doi-asserted-by":"publisher","first-page":"2780","DOI":"10.1007\/s00259-019-04468-4","volume":"46","author":"J Cui","year":"2019","unstructured":"Cui J, Gong K, Guo N, Wu C, Meng X, Kim K, et al. PET image denoising using unsupervised deep learning. Eur J Nucl Med Mol Imaging. 2019 Dec;46(13):2780\u20139.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"2","key":"1542_CR50","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1053\/j.semnuclmed.2020.08.003","volume":"51","author":"R Seifert","year":"2021","unstructured":"Seifert R, Weber M, Kocakavuk E, Rischpler C, Kersting D. Artificial intelligence and machine learning in nuclear medicine: future perspectives. Semin Nucl Med. 2021 Mar;51(2):170\u20137.","journal-title":"Semin Nucl Med"},{"issue":"1","key":"1542_CR51","doi-asserted-by":"publisher","first-page":"134","DOI":"10.2967\/jnumed.117.195420","volume":"59","author":"J Li","year":"2018","unstructured":"Li J, Zheng H, Fodah R, Warawa JM, Ng CK. Validation of 2-18F-fluorodeoxysorbitol as a potential radiopharmaceutical for imaging bacterial infection in the lung. J Nucl Med. 2018;59(1):134\u20139.","journal-title":"J Nucl Med"},{"issue":"5","key":"1542_CR52","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/j.jcmg.2018.02.011","volume":"12","author":"K Takemiya","year":"2019","unstructured":"Takemiya K, Ning X, Seo W, Wang X, Mohammad R, Joseph G, et al. Novel PET and near infrared imaging probes for the specific detection of bacterial infections associated with cardiac devices. JACC Cardiovasc Imaging. 2019;12(5):875\u201386.","journal-title":"JACC Cardiovasc Imaging"},{"key":"1542_CR53","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1021\/acsinfecdis.8b00061","volume":"4","author":"CA Mutch","year":"2018","unstructured":"Mutch CA, Ordonez AA, Qui H, Parker M, Bambarger LE, Villanueva-Meyer JE, et al. [11C]Para-aminobenzoic acid: a positron emission tomography tracer targeting bacteria-specific metabolism. ACS Infect Dis. 2018;4:1067\u201372.","journal-title":"ACS Infect Dis"},{"issue":"2","key":"1542_CR54","doi-asserted-by":"publisher","first-page":"197","DOI":"10.3390\/jcm8020197","volume":"8","author":"S Auletta","year":"2019","unstructured":"Auletta S, Varani M, Horvat R, Galli F, Signore A, Hess S. PET radiopharmaceuticals for specific bacteria imaging: a systematic review. J Clin Med. 2019 Feb 6;8(2):197.","journal-title":"J Clin Med"}],"container-title":["Current Cardiology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11886-021-01542-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11886-021-01542-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11886-021-01542-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,5]],"date-time":"2023-02-05T14:34:23Z","timestamp":1675607663000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11886-021-01542-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,7]]},"references-count":54,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["1542"],"URL":"https:\/\/doi.org\/10.1007\/s11886-021-01542-y","relation":{},"ISSN":["1523-3782","1534-3170"],"issn-type":[{"value":"1523-3782","type":"print"},{"value":"1534-3170","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,7]]},"assertion":[{"value":"18 March 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}},{"value":"Dr. ten Hove, Dr. Glaudemans, Dr. Slart, and Dr. Sinha report the aforementioned institutional funding through PUSH. Additionally, Dr. Sinha reports grants from Beatrixoord Foundation, grants from the European Union, outside the submitted work, and Committee work (executive boards) on a local and national level dealing with guideline development of infections. Dr. Budde reports grants from HeartFlow and Siemens, outside the submitted work.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}],"article-number":"130"}}